|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and18fluorodeoxyglucose (FDG) positron emission tomography (PET) |
Vir: |
|
|
|
List of services to meet your request
Contains list of services for current record
|
|
|
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
|